1. Inhibitory effects of dipyridamole on growth, nucleoside incorporation and platelet-activating capability in the U87MG and SKNMC human tumor cell lines;Bastida;Cancer Res.,1985
2. Phase I trial of dipyridamole with 5-Fluorouracil and folinic acid;Budd;Cancer Res.,1990
3. Mechanisms of synergy between N-Phosphonacetyl-l-aspartate and dipyridamole in a human ovarian carcinoma cell line;Chan;Cancer Res.,1985
4. Plasma uridine changes in cancer patients treated with the combination of dipyridamole and N-Phosphonacetyl-l-aspartate;Chan;Cancer Res.,1986
5. Effect of chemical modifiers on the toxicity of mitoxantrone towards CHO-K-a cells in vitro;Desai,1989